Liquidia (LQDA) Total Liabilities (2019 - 2026)
Liquidia's (LQDA) quarterly Total Liabilities came in at $293.0 million in Q1 2026, up 64.84% year-on-year from $177.7 million in Q1 2025, and up 3.45% quarter-over-quarter from $283.2 million in Q4 2025.
Liquidia (LQDA) Total Liabilities (2019 - 2026) Analysis & Trends
Liquidia's Total Liabilities history runs 8 years deep, the most recent figure standing at $293.0 million for Q1 2026.
- On a quarterly basis, Total Liabilities rose 64.84% year-over-year to $293.0 million in Q1 2026; TTM through Mar 2026 was $293.0 million, a 64.84% increase from a year earlier, with the FY2025 full-year figure at $283.2 million, up 87.62% from the prior year.
- Total Liabilities improved to $293.0 million in Q1 2026 per LQDA's latest filing, from $283.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $293.0 million in Q1 2026 and bottomed at $37.0 million in Q2 2022.
- The 5-year median for Total Liabilities is $100.0 million (2024), against an average of $126.6 million.
- Across the five-year window, Total Liabilities rose 23.97% in 2023 and surged 123.73% in 2024, its largest moves.
- Year by year, Total Liabilities stood at $38.8 million in 2022, then surged by 83.2% to $71.0 million in 2023, then surged by 112.47% to $150.9 million in 2024, then surged by 87.62% to $283.2 million in 2025, then advanced by 3.45% to $293.0 million in 2026.
- Per Business Quant, the three latest LQDA Total Liabilities figures stand at $293.0 million (Q1 2026), $283.2 million (Q4 2025), and $253.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 292.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 292.95 Mn |
| Dec 31, 2025 | 283.19 Mn |
| Sep 30, 2025 | 253.93 Mn |
| Jun 30, 2025 | 242.22 Mn |
| Mar 31, 2025 | 177.72 Mn |
| Dec 31, 2024 | 150.94 Mn |
| Sep 30, 2024 | 142.37 Mn |
| Jun 30, 2024 | 114.64 Mn |
| Mar 31, 2024 | 100.01 Mn |
| Dec 31, 2023 | 71.04 Mn |
| Sep 30, 2023 | 63.64 Mn |
| Jun 30, 2023 | 60.94 Mn |
| Mar 31, 2023 | 47.28 Mn |
| Dec 31, 2022 | 38.78 Mn |
| Sep 30, 2022 | 37.53 Mn |
| Jun 30, 2022 | 36.98 Mn |
| Mar 31, 2022 | 38.14 Mn |
| Dec 31, 2021 | 28.46 Mn |
| Sep 30, 2021 | 27.34 Mn |
| Jun 30, 2021 | 25.36 Mn |